Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity
Testosterone prescribed for sexual dysfunction or off-label indications may face coverage denials
The advantages of GLP-1 agonists include substantial clinical trial data supporting their efficacy and safety, FDA approval for weight management in certain populations, proven results with many users losing 15-20% or more of body weight, and effects on appetite that make caloric restriction feel natural
Moving BAC water in and out of refrigeration
Such modulatory effects on cholesterol levels hint at its broader applicability, beyond just weight reduction, perhaps in the realm of metabolic health optimization [Usman et al., 2022]
My dad was diabetic and injected subcutaneously, alternating between tummy and thighs